Terns Pharmaceuticals Overview
Terns Pharmaceuticals Target Price
Terns Pharmaceuticals target price — quarterly history, peer benchmarks, and growth trends.
Get informed when a big investor buys or sells
+ FollowShare Price
$52.95
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-03-27 | Mizuho Securities | $53 |  0.1% upside |  |
| 2026-02-09 | Leerink Partners | $58 | 9.5% upside | |
| 2025-12-10 | JefferiesAkash Tewari | $70 | 32.2% upside | |
| 2025-12-09 | Oppenheimer | $58 | 9.5% upside | |
| 2025-12-09 | BMO Capital | $54 | 2% upside | |
| 2025-12-09 | Truist Financial | $56 | 5.8% upside | |
| 2025-12-09 | Mizuho Securities | $54 | 2% upside | |
| 2025-12-09 | H.C. Wainwright | $60 | 13.3% upside | |
| 2025-12-09 | BarclaysEtzer Darout | $56 | 5.8% upside | |
| 2025-11-28 | Mizuho SecuritiesGraig Suvannavejh | $33 |  37.7% downside | |
| 2025-11-26 | JMP Securities | $35 | 33.9% downside | |
| 2025-11-25 | BarclaysEtzer Darout | $36 | 32% downside | |
| 2025-11-18 | BMO Capital | $30 | 43.3% downside | |
| 2025-11-11 | Barclays | $28 | 47.1% downside | |
| 2025-11-04 | H.C. Wainwright | $20 | 62.2% downside | |
| 2025-11-04 | Truist Financial | $28 | 47.1% downside | |
| 2025-11-04 | Barclays | $27 | 49% downside | |
| 2025-11-03 | BMO CapitalEvan Seigerman | $22 | 58.5% downside | |
| 2025-11-03 | OppenheimerJay Olson | $24 | 54.7% downside | |
| 2025-11-03 | Jefferies | $35 | 33.9% downside | |
| 2025-10-23 | JMP SecuritiesSilvan Tuerkcan | $15 | 71.7% downside | |
| 2025-10-22 | Mizuho SecuritiesGraig Suvannavejh | $9 | 83% downside | |
| 2025-10-22 | Oppenheimer | $17 | 67.9% downside | |
| 2025-10-22 | BarclaysEtzer Darout | $14 | 73.6% downside | |
| 2025-10-14 | Truist Financial | $20 | 62.2% downside | |
| 2025-09-16 | Barclays | $15 | 71.7% downside | |
| 2024-12-03 | OppenheimerJay Olson | $20 | 62.2% downside | |
| 2024-09-16 | BMO CapitalEtzer Darout | $26 | 50.9% downside | |
| 2024-08-21 | Mizuho SecuritiesGraig Suvannavejh | $10 | 81.1% downside | |
| 2024-03-15 | BMO CapitalEtzer Darout | $19 | 64.1% downside | |
| 2022-12-29 | H.C. Wainwright | $7 | 86.8% downside | |
| 2022-12-20 | Goldman Sachs | $14 | 73.6% downside | |
| 2022-09-27 | Goldman SachsCorinne Jenkins | $9 | 83% downside | |